Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix and Toppan Printing to Develop and Market Microarrays

CombiMatrix said today that it has formed a strategic alliance with Toppan Printing to develop and manufacture microarrays that use electrochemical detection.

 

Toppan of Tokyo, Japan, will pay CombiMatrix, a subsidiary of Acacia Research, an upfront fee of $1 million as well as additional development and milestone fees. Toppan will manufacture microarrays for CombiMatrix and its partners and share revenues and royalties on these.

 

The two companies plan to co-develop semiconductor microarrays for applications in research and diagnostics. Unlike microarrays that CombiMatrix has developed in collaboration with Roche, which use optical detection, these arrays will rely on electrochemical detection.

 

CombiMatrix said it has already tested this technology in small prototype instruments and assays for biological and chemical defense applications.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.